PostEra is building a modern 21st century biopharma company focused on accelerating the discovery of new medicines for patients. The company leverages Proton, its AI platform for medicinal chemistry, to streamline the drug discovery process by integrating machine learning into the design, make, and test cycle.
PostEra addresses the longstanding challenges in drug discovery—high costs, long timelines, and high failure rates—by combining proprietary data with advanced chemistry foundation models. Their platform enables faster identification of viable drug candidates, more efficient synthesis planning, and optimized testing cycles.
The company collaborates with leading pharmaceutical partners such as Pfizer and Amgen, and has contributed to global efforts like the COVID Moonshot initiative. PostEra's technology is validated through peer-reviewed publications and real-world applications in both academic and industrial settings.